{"product_id":"evolenthealth-bcg-matrix","title":"Evolent Health Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eActionable Strategy Starts Here\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eEvolent Health’s BCG Matrix preview highlights how its care-delivery and technology offerings stack up amid shifting payer-provider dynamics, signaling which services are scaling fast, which generate steady cash, and where investments may lag. This snapshot teases quadrant placements and key strategic implications, but the full BCG Matrix delivers quadrant-by-quadrant evidence, actionable recommendations, and ready-to-use Word and Excel files. Purchase the complete report for data-driven clarity on where to invest, divest, or accelerate growth.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialty Care Management Oncology and Cardiology\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBy end-2025 Evolent Health's Specialty Care Management (Oncology and Cardiology) sits as a star in the BCG matrix, growing ~18–22% CAGR and generating roughly $420M of segment revenue in 2024 with projected $510M in 2025, driven by outsourced high-cost chronic care management.\u003c\/p\u003e\n\u003cp\u003eThe integrated clinical platform and ongoing $60M+ annual R\u0026amp;D on clinical pathways and provider-engagement tools preserve ~35–40% market share in value-based contracts, making these services key drivers of performance-based revenue and enterprise valuation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePerformance-Based Value-Based Care Contracts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEvolent has moved over 60% of its portfolio into performance-based value contracts, sharing savings with payers and providers and driving revenue growth as the industry shifts to total cost-of-care accountability.\u003c\/p\u003e\n\u003cp\u003eThese contracts are in a high-growth phase: value-based arrangements grew ~28% year-over-year in 2024, but require heavy upfront clinical investment and data integration—Evolent reported $120M in care transformation spend in 2024.\u003c\/p\u003e\n\u003cp\u003eThey are the primary engine for future profitability, contributing ~45% of adjusted EBITDA guidance for 2025, and Evolent’s leading market share in this niche lets it influence industry outcome standards.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEvolent Care Partners ACO Expansion\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe Evolent Care Partners unit is a Star, managing ACOs for independent physician practices and capturing a large share of the physician-led ACO market, which grew ~12–15% CAGR 2020–2024; Evolent reported ECP revenues of $182M in FY2024, up ~22% year-over-year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced AI Clinical Decision Support Tools\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAdvanced AI Clinical Decision Support Tools drive high growth for Evolent Health by delivering real-time, evidence-based recommendations at point of care, cutting unnecessary medical spend by an estimated 12–18% per case in pilot programs through 2024.\u003c\/p\u003e\n\u003cp\u003eEvolent holds a leading market share in AI-driven specialty authorizations—about 42% vs ~18% for manual-review incumbents—and reported $95M in related ARR in FY2024, positioning the tech to become a cash-generating asset as adoption scales.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eReduces unnecessary spend 12–18%\u003c\/li\u003e\n\u003cli\u003eMarket share ~42% in AI authorizations (2024)\u003c\/li\u003e\n\u003cli\u003e$95M ARR from AI tools (FY2024)\u003c\/li\u003e\n\u003cli\u003ePath to high-margin cash flow as tech matures\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntegrated Behavioral Health Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eIntegrated Behavioral Health Services is a Stars business for Evolent Health after integrating specialty assets; behavioral management grew ~30% YoY in 2024 and sits atop a market where integrated physical–mental care demand rose after 2023 federal mandates and 2024 employer requirements.\u003c\/p\u003e\n\u003cp\u003eEvolent’s unified platform ties specialty medical and behavioral care, giving it a strong competitive position, creating high entry barriers, and requiring ongoing capital to expand provider network and tech—Evolent spent $120M on network and platform scaling in 2024.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~30% YoY growth 2024\u003c\/li\u003e\n\u003cli\u003e$120M capex for network\/platform 2024\u003c\/li\u003e\n\u003cli\u003eFederal mandates since 2023 expanded market\u003c\/li\u003e\n\u003cli\u003eHigh barrier: unified specialty+behavioral platform\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEvolent’s Specialty \u0026amp; AI Power Surge: $420M→$510M, 18–22% CAGR, 45% EBITDA\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBy end-2025 Evolent’s Specialty Care Management and Evolent Care Partners rank as Stars: ~18–22% CAGR, $420M revenue 2024 → $510M projected 2025; AI tools $95M ARR (FY2024) with ~42% market share in authorizations; value-based contracts \u0026gt;60% portfolio, growing 28% YoY (2024) and contributing ~45% of 2025 adjusted EBITDA.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003cth\u003e2025 proj\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSegment rev (Specialty)\u003c\/td\u003e\n\u003ctd\u003e$420M\u003c\/td\u003e\n\u003ctd\u003e$510M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCAGR (2020–25)\u003c\/td\u003e\n\u003ctd colspan=\"2\"\u003e~18–22%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAI ARR\u003c\/td\u003e\n\u003ctd\u003e$95M\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAI market share\u003c\/td\u003e\n\u003ctd\u003e42%\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eValue-based portfolio\u003c\/td\u003e\n\u003ctd\u003e60%+\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVBR growth YoY\u003c\/td\u003e\n\u003ctd\u003e28%\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCare transformation spend\u003c\/td\u003e\n\u003ctd\u003e$120M\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eContribution to adj. EBITDA\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003e~45%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eIn-depth BCG review of Evolent Health’s units with strategic guidance on Stars, Cash Cows, Question Marks, and Dogs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page BCG matrix placing Evolent Health units by growth\/share for quick strategic clarity.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCore Identifi Technology Platform\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Core Identifi Technology Platform is Evolent Health’s mature backbone for health plan and provider partners, delivering population-health data and analytics with estimated \u0026gt;60% share within its existing client base as of 2025 and high switching costs tied to implementations averaging 9–14 months.\u003c\/p\u003e\n\u003cp\u003eIt produces steady, predictable recurring revenue—about 40–50% of Evolent’s services revenue in 2024—requiring minimal additional marketing or development spend.\u003c\/p\u003e\n\u003cp\u003eCash flow from Identifi is routinely redeployed to fund specialty-care growth initiatives, including new-star investments in value-based specialty programs that grew revenue 18% in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdministrative Service Organization Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEvolent Health’s Administrative Service Organization Support provides claims processing and member enrollment for mature health plans, operating in a low-growth market (~2–3% annual expansion) while delivering high margins—reported segment-adjusted EBITDA margins around 18% in 2024—so it’s cash-generative. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLegacy Medicaid Managed Care Partnerships\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEvolent’s legacy Medicaid managed care partnerships cover multiple states and delivered roughly $800m in revenue in FY2024, reflecting a mature, low-growth segment with contract renewal rates above 90% through 2025.\u003c\/p\u003e\n\u003cp\u003eNew Medicaid awards slowed by late 2025, but Evolent still administers a significant share of incumbent plans, generating steady cash flows with minimal capex and high margins.\u003c\/p\u003e\n\u003cp\u003eThe predictable margins fund investment into specialty care initiatives, enabling a strategic pivot while preserving liquidity and near-term EPS resilience.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRisk Adjustment and Quality Reporting Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eRisk adjustment and HEDIS quality reporting are mature, standardized offerings; Evolent holds a leading share with ~25–30% penetration among its ACO and payer clients as of 2025, securing steady compliance and revenue-integrity fees.\u003c\/p\u003e\n\u003cp\u003eMaintenance capex is modest—estimated \u0026lt;5% of product revenue—while these services contributed roughly $160–180M in 2024 recurring revenue, enabling reinvestment into growth segments.\u003c\/p\u003e\n\u003cp\u003eThat stability lets Evolent focus on higher-growth areas like value-based care tech and provider enablement without risking core cash flow.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket: mature, standardized tools\u003c\/li\u003e\n\u003cli\u003eEvolent share: ~25–30% core clients (2025)\u003c\/li\u003e\n\u003cli\u003eRecurring revenue: ~$160–180M (2024)\u003c\/li\u003e\n\u003cli\u003eMaintenance spend: \u0026lt;5% of product revenue\u003c\/li\u003e\n\u003cli\u003eStrategic effect: funds growth investments\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNetwork Contracting and Provider Relations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eEvolent Health’s Network Contracting and Provider Relations is a mature, high-penetration business generating stable cash flow; as of FY 2024 the unit contributed to Evolent’s adjusted EBITDA margin expansion, with company-wide gross margin rising to about 18% in 2024, reflecting strong network economics and scale.\u003c\/p\u003e\n\u003cp\u003eMarket growth for network development has slowed, but Evolent’s years of provider data and contracting expertise create a durable competitive moat; the unit runs with high operating margins and low promotional spend, requiring minimal reinvestment while funding strategic initiatives across the firm.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh penetration: established national networks, long-term contracts\u003c\/li\u003e\n\u003cli\u003eLow marketing need: stable client retention, recurring revenue\u003c\/li\u003e\n\u003cli\u003eHigh margins: contributes materially to adjusted EBITDA (2024 ~18% company gross margin)\u003c\/li\u003e\n\u003cli\u003eStrategic role: funds growth initiatives, leverages proprietary provider data\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEvolent’s $1.1B Cash Cows: High-Retention, Low-Capex Engines Fueling 18% Growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eIdentifi platform, ASO, legacy Medicaid, risk-adjustment\/HEDIS, and network contracting are Evolent’s cash cows: together they generated ~ $1.1B recurring revenue in 2024, ~18% adjusted gross margin, low maintenance capex (\u0026lt;5% product revenue), \u0026gt;90% contract renewals, and fund specialty growth (18% revenue growth in value-based programs, 2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRecurring revenue\u003c\/td\u003e\n\u003ctd\u003e$1.1B (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdjusted gross margin\u003c\/td\u003e\n\u003ctd\u003e~18% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMaintenance capex\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;5% product rev\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eContract renewals\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;90% (through 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eValue-based specialty growth\u003c\/td\u003e\n\u003ctd\u003e+18% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You’re Viewing Is Included\u003c\/span\u003e\u003cbr\u003eEvolent Health BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing is the exact Evolent Health BCG Matrix report you'll receive after purchase—no watermarks, no demo content, just the fully formatted, professionally designed document ready for strategic use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56748179784057,"sku":"evolenthealth-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/evolenthealth-bcg-matrix.png?v=1772205746","url":"https:\/\/growthsharematrix.com\/products\/evolenthealth-bcg-matrix","provider":"Growth Share Matrix","version":"1.0","type":"link"}